This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

EpiCast Report: Dermatophytic Onychomycosis - Epidemiology Forecast To 2022

Table of Contents

1 Table of Contents 4

1.1 List of Tables 5

1.2 List of Figures 6

2 Introduction 7

2.1 Catalyst 7

3 Epidemiology 8

3.1 Risk Factors and Comorbidities 8

3.1.1 Poor peripheral circulation is greater in older men 9

3.1.2 Household contact with other DO patients increases risk of infection 2.5 times 9

3.1.3 Immunosuppression increases susceptibility to DO infections 10

3.1.4 Prevalence of dermatophytic onychomycosis is higher in diabetics than in non-diabetics 11

3.2 Global Trends 12

3.2.1 US 12

3.2.2 5EU 13

3.2.3 Japan 14

3.3 Forecast Methodology 15

3.3.1 Sources Used 16

3.3.2 Forecast Assumptions and Methods 18

3.3.3 Sources Not Used 20

3.4 Epidemiology Forecast (2012–2022) 21

3.4.1 Prevalent Cases of Dermatophytic Onychomycosis 21

3.4.2 Age-Specific Prevalent Cases of Dermatophytic Onychomycosis 23

3.4.3 Sex-Specific Prevalent Cases of Dermatophytic Onychomycosis 25

3.4.4 Age-Standardized Prevalence of Dermatophytic Onychomycosis 27

3.5 Discussion 28

3.5.1 Limitations of the Analysis 29

3.5.2 Strengths of the Analysis 29

4 Appendix 30

4.1 Bibliography 30

4.2 About the Authors 33

4.2.1 Epidemiologists 33

4.2.2 Reviewers 33

4.2.3 Global Director of Epidemiology and Clinical Trials Analysis 34

4.2.4 Global Head of Healthcare 35

4.3 About GlobalData 35

4.4 About EpiCast 36

4.5 Contact Us 36

4.6 Disclaimer 36

List of Tables

Table 1: Risk Factors and Comorbidities for Dermatophytic Onychomycosis 8

Table 2: Seven Major Markets, Sources of Dermatophytic Onychomycosis Prevalence Data 15

Table 3: Seven Major Markets, Total Prevalent Cases of Dermatophytic Onychomycosis, Ages ?15 Years, Men and Women, Selected Years, 2012–2022 21

Table 4: Seven Major Markets, Total Prevalent Cases of Dermatophytic Onychomycosis, by Age, Men and Women, N = Millions (Row %), 2012 23

Table 5: Seven Major Markets, Total Prevalent Cases of Dermatophytic Onychomycosis, by Sex, Ages ? 15 Years, N=Millions, (Row %), 2012 25

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,135.72 +38.82 0.21%
S&P 500 2,101.04 +2.51 0.12%
NASDAQ 4,982.8090 +15.6680 0.32%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs